Actavis Recalls Pain Patches Over Dosage Fears
The U.S. unit of Icelandic pharmaceutical maker Actavis Group said Thursday it was pulling lots of its fentanyl transdermal system patches from retailers and wholesalers in the United States. The affected patches come in a 25 mcg per hour dose, the company said.
Morristown, N.J.-based Actavis identified one patch in a single lot that released the active ingredient faster...
To view the full article, register now.